Correction: Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients

BMC Nephrol. 2022 Sep 26;23(1):321. doi: 10.1186/s12882-022-02950-0.

Bihua Wang^{1

2}, Zhidan Zhu^{1

2}, Feng Huang^{1

2}, Haowen Huang³, Luxia Tu⁴, Ying Wang¹, Linfeng Zheng¹, Jing Zhou¹, Xin Wei⁵

¹ Department of Nephrology, The First Affiliated Hospital of Nanchang University, 17 Yongwai Zhengjie, Nanchang City, 330006, Jiangxi, China.
² Nanchang University, Nanchang City, 330006, China.
³ Department of Nephrology, People's Hospital of Ganjiang New District, Nanchang City, 330006, Jiangxi, China.
⁴ Pathology Department, The First Affiliated Hospital of Nanchang University, Nanchang City, China.
⁵ Department of Nephrology, The First Affiliated Hospital of Nanchang University, 17 Yongwai Zhengjie, Nanchang City, 330006, Jiangxi, China. weixin842270@126.com.

No abstract available

Publication types